Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 21-1458
RSS Feed Print Notify Me
Search documents in this case:
No. 21-1458
Title:EPA Drug Initiative II, Petitioner
v.
Hikma Pharmaceuticals USA Inc., et al.
Docketed:May 18, 2022
Lower Ct:United States Court of Appeals for the Federal Circuit
   Case Numbers:(2021-2024)
   Decision Date:February 15, 2022
   Rehearing Denied:
  Discretionary Court Decision Date:

DateProceedings and Orders
May 16 2022Petition for a writ of certiorari filed. (Response due June 17, 2022)
PetitionCertificate of Word CountProof of Service
May 20 2022Waiver of right of respondents Hikma Pharmaceuticals USA Inc.; Hikma Pharmaceuticals International Limited; West-Ward Pharmaceuticals International Limited (n/k/a Hikma Pharmaceuticals International Limited) to respond filed.
Main Document
May 23 2022Waiver of right of respondent Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. to respond filed.
Main Document
Jun 07 2022DISTRIBUTED for Conference of 6/23/2022.
Jun 27 2022Petition DENIED.

NAMEADDRESSPHONE
Attorneys for Petitioner
Michael Scott Kasanoff
    Counsel of Record
Michael S. Kasanoff, LLC
9 Stillwell Street
Matawan, NJ 07747

mkasanoff@att.net
908-902-5900
Party name: EPA Drug Initiative II
Attorneys for Respondents
Charles Bennett Klein
    Counsel of Record
Winston & Strawn LLP
1901 L Street NW
Washington, DC 20036

cklein@winston.com
202-282-5977
Party name: Hikma Pharmaceuticals USA Inc.; Hikma Pharmaceuticals International Limited; West-Ward Pharmaceuticals International Limited (n/k/a Hikma Pharmaceuticals International Limited)
Constance S. HunterWindels Marx Lane & Mittendorf, LLP
One Giralda Farms
Madision, NJ 07006

chuttner@windelsmarx.com
973-966-3206
Party name: Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.

 

SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543